SAI Life Sciences Ltd Executive and Leadership Team

Rohan Jadhav, the Chief Executive Officer at SAI Life Sciences Ltd, directs the overarching corporate strategy and operational execution. This leadership role involves guiding the company's expansion within the pharmaceutical and biotechnology sectors, ensuring alignment with market demands for drug discovery, development, and manufacturing services. Jadhav's focus centers on driving innovation and efficiency across all business units, from synthetic chemistry to formulation development. The Chief Executive Officer's responsibilities include fostering strategic partnerships and overseeing the integration of new technologies to enhance service offerings. By championing a culture of scientific excellence, Rohan Jadhav ensures the company maintains its competitive edge in delivering high-quality solutions to clients worldwide. This executive's vision shapes the company's trajectory, emphasizing sustainable growth and a robust pipeline of client projects.

Krishna Kanumuri, the Chief Executive Officer & Managing Director at SAI Life Sciences Ltd, spearheads the company's strategic direction and operational management. This dual role encompasses driving business growth, overseeing all facets of drug discovery, development, and manufacturing services, and ensuring the company's long-term vision is realized. Kanumuri's leadership focuses on enhancing the company's capabilities in synthetic and medicinal chemistry, biology services, and formulation development across both NCE and generic products. The Chief Executive Officer & Managing Director's mandate includes fostering strong client relationships and expanding the company's global footprint. By championing operational excellence and scientific rigor, Krishna Kanumuri ensures SAI Life Sciences Ltd remains a trusted partner for pharmaceutical and biotechnology firms seeking comprehensive R&D solutions. This executive's strategic oversight is critical for navigating the complexities of the life sciences industry and achieving sustained market leadership.

Gautham Manoj, the Chief of Staff at SAI Life Sciences Ltd, provides critical support to executive leadership, facilitating strategic initiatives and operational efficiency. This role involves coordinating cross-functional projects, managing key stakeholder communications, and ensuring the seamless execution of company-wide objectives. Manoj's responsibilities extend to streamlining internal processes and driving the implementation of strategic plans across departments, including drug discovery and development services. The Chief of Staff's contribution is vital in optimizing resource allocation and enhancing overall organizational performance. By acting as a central point of coordination, Gautham Manoj ensures that executive priorities are translated into actionable plans, supporting the company's mission to deliver advanced pharmaceutical solutions. This executive's efforts are instrumental in maintaining momentum and achieving strategic milestones within the dynamic life sciences landscape.

Khursheed Syed, the Chief of Staff - CMC at SAI Life Sciences Ltd, directs strategic operations and oversight for Chemistry, Manufacturing, and Controls (CMC) functions. This leadership position is crucial for ensuring the seamless integration of drug discovery, development, and manufacturing services, particularly concerning formulation and re-formulation processes. Syed's responsibilities include optimizing CMC workflows, enhancing regulatory compliance, and driving efficiency in product development lifecycles. The Chief of Staff - CMC's role involves close collaboration with research and development teams to translate scientific advancements into scalable manufacturing solutions. By focusing on critical CMC aspects, Khursheed Syed ensures the quality and timely delivery of pharmaceutical products, supporting the company's commitment to its clients. This executive's expertise is fundamental to navigating the complex regulatory and technical demands of the pharmaceutical industry.

Anil Chilagani, the Chief Revenue Officer, Agm Disovery Oe Lead ( Business) at SAI Life Sciences Ltd, drives revenue generation and business development initiatives, with a specific focus on discovery operations. This executive's mandate includes expanding the company's client base and increasing market share within the pharmaceutical and biotechnology sectors. Chilagani oversees the commercial strategy for drug discovery services, ensuring alignment between client needs and the company's service offerings. The Chief Revenue Officer's responsibilities encompass managing sales pipelines, forging strategic partnerships, and optimizing revenue streams across all business units. By championing a client-centric approach, Anil Chilagani ensures that SAI Life Sciences Ltd continues to deliver exceptional value and innovative solutions. This executive's leadership is pivotal in achieving financial growth and solidifying the company's position as a leader in R&D services.